Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds specifically-identified oligosaccharide structure
Patent
1995-06-06
1998-12-08
Eisenschenk, Frank C.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds specifically-identified oligosaccharide structure
4241431, 4241551, 4241741, 4241791, 4241811, 4241831, A61K 39395
Patent
active
058465359
ABSTRACT:
The subject invention relates to methods for reducing tumor cell growth in a mammal by administering compositions which include an antibody having the binding specificity of a monoclonal antibody selected from the group comprising one of those referred to as B1, B3 or B5 conjugated to a toxin, radionuclide or drug.
REFERENCES:
Kreitman, R.J. , et al., Abstract, "Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor alpha at different locations in Pseudomonas exotoxin, " Bioconjug Chem, 3(1) :63-8 (1992 Jan-Feb).
Benhar, I., et al. , "Characterization of B1 (Fv) PE38 and B1 (dsFv) pE38: Single-Chain and Disulfide-stabilized Fv Immunotoxins with Increased Activity That Cause Complete Remissions of Established Human Carcinoma Xenografts in Nude Mice, " Clinical Cancer Resarch,vol. 1, pp. 1023-1029 (Sept. 1995).
Pastan Ira
Willingham Mark C.
Eisenschenk Frank C.
The United States of America as represented by the Department of
LandOfFree
Methods for reducing tumor cell growth by using antibodies with does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for reducing tumor cell growth by using antibodies with , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for reducing tumor cell growth by using antibodies with will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-174568